Search Results - "Moes, D.J.A.R."

Clinical pharmacokinetics and pharmacogenetics of tamoxifen and endoxifen by Sanchez-Spitman, A B, Swen, J J, Dezentje, V O, Moes, D J A R, Gelderblom, H, Guchelaar, H J

“…: Tamoxifen dominates the anti-estrogenic therapy in the early and metastatic breast cancer setting. Tamoxifen has a complex metabolism, being mainly…”
Get more information

Population pharmacokinetics and pharmacogenetics of once daily tacrolimus formulation (Advagraf®) in liver transplant patients by Moes, D.J.A.R, Bent, S.A.S, Swen, J.J, van der Straaten, T, Verspaget, H.W, Guchelaar, H.J, den Hartigh, J, van Hoek, B

Get full text

Therapeutic drug monitoring-based precision dosing of oral targeted therapies in oncology: a prospective multicenter study by Groenland, S.L., van Eerden, R.A.G., Westerdijk, K., Meertens, M., Koolen, S.L.W., Moes, D.J.A.R., de Vries, N., Rosing, H., Otten, H., Vulink, A.J.E., Desar, I.M.E., Imholz, A.L.T., Gelderblom, H., van Erp, N.P., Beijnen, J.H., Mathijssen, R.H.J., Huitema, A.D.R., Steeghs, N.

“…Oral targeted therapies show a high pharmacokinetic (PK) interpatient variability. Even though exposure has been positively correlated with efficacy for many…”
Get full text

Incidence of clinically significant toxicities in patients with high endoxifen concentrations by Groenland, S.L., Sanchez-Spitman, A.B., Moes, D.J.A.R., Koolen, S.L., Dezentjé, V.O., van Erp, N., Mathijssen, R.H.J., Guchelaar, H.-J., Huitema, A.D.R., Steeghs, N.

Get full text

Prevalence of medication transfer errors in nephrology patients and potential risk factors by Ebbens, M.M., Errami, H., Moes, D.J.A.R., van den Bemt, P.M.L.A., van der Boog, P.J.M., Gombert-Handoko, K.B.

“…Medication reconciliation in transitions of care can prevent medication transfer errors (MTE). MTE can cause patient harm. Since performing medication…”
Get full text

Sunitinib for the treatment of metastatic gastrointestinal stromal tumors: the effect of TDM-guided dose optimization on clinical outcomes by Giraud, E.L., Westerdijk, K., van der Kleij, M.B.A., Guchelaar, N.A.D., Meertens, M., Bleckman, R.F., Rieborn, A., Mohammadi, M., Roets, E., Mathijssen, R.H.J., Huitema, A.D.R., Koolen, S.L.W., Gelderblom, H., Moes, D.J.A.R., Reyners, A.K.L., Touw, D.J., Keizer-Heldens, P., Oosten, A.W., van der Graaf, W.T.A., Steeghs, N., van Erp, N.P., Desar, I.M.E.

“…Sunitinib is an oral anticancer drug approved for the treatment of among others gastrointestinal stromal tumor (GIST). Previous analyses demonstrated an…”
Get full text

The effect of CYP3A422 , CYP3A53 and CYP3A combined genotypes on cyclosporine, everolimus and tacrolimus pharmacokinetics in renal transplant recipients by D.J.A.R., Moes, Swen, J.J, den Hartigh, J, van der Straaten, T, Homan van der Heide, J.J, Sanders, J.S, Bemelman, F.J, de Fijter, J.W, Guchelaar, H.-J

Get full text